In last trading session, ORIC Pharmaceuticals Inc (NASDAQ:ORIC) saw 0.89 million shares changing hands with its beta currently measuring 1.51. Company’s recent per share price level of $10.5 trading at $0.27 or 2.64% at ring of the bell on the day assigns it a market valuation of $894.85M. That closing price of ORIC’s stock is at a discount of -39.71% from its 52-week high price of $14.67 and is indicating a premium of 62.86% from its 52-week low price of $3.90. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.02 million shares which gives us an average trading volume of 1.19 million if we extend that period to 3-months.
For ORIC Pharmaceuticals Inc (ORIC), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.10. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
ORIC Pharmaceuticals Inc (NASDAQ:ORIC) trade information
Upright in the green during last session for gaining 2.64%, in the last five days ORIC remained trading in the green while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $10.5 price level, adding 4.46% to its value on the day. ORIC Pharmaceuticals Inc’s shares saw a change of 46.85% in year-to-date performance and have moved 13.88% in past 5-day. ORIC Pharmaceuticals Inc (NASDAQ:ORIC) showed a performance of 81.66% in past 30-days. Number of shares sold short was 12.71 million shares which calculate 6.98 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 12 to the stock, which implies a rise of 12.5% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 12. It follows that stock’s current price would drop -14.29% in reaching the projected high whereas dropping to the targeted low would mean a loss of -14.29% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -15.32% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 3.91% while estimates for its earnings growth in next 5 years are of 3.17%.
ORIC Pharmaceuticals Inc (NASDAQ:ORIC)’s Major holders
Insiders are in possession of 7.93% of company’s total shares while institution are holding 102.70 percent of that, with stock having share float percentage of 111.54%. Investors also watch the number of corporate investors in a company very closely, which is 102.70% institutions for ORIC Pharmaceuticals Inc that are currently holding shares of the company. NEXTECH INVEST LTD. is the top institutional holder at ORIC for having 5.29 million shares of worth $37.37 million. And as of 2024-06-30, it was holding 7.5136 of the company’s outstanding shares.
The second largest institutional holder is FMR LLC, which was holding about 4.92 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.9943 of outstanding shares, having a total worth of $34.79 million.
